Shopping Cart
- Remove All
- Your shopping cart is currently empty
CYD-2-88 (BDA-366 analog) is an analog of BDA-366 (Bcl2 BH4 antagonist). Administered through intraperitoneal injection at a dosage of 20 mg/kg, CYD-2-88 effectively inhibits tumor growth in mice with NSCLC H460 xenografts.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | CYD-2-88 (BDA-366 analog) is an analog of BDA-366 (Bcl2 BH4 antagonist). Administered through intraperitoneal injection at a dosage of 20 mg/kg, CYD-2-88 effectively inhibits tumor growth in mice with NSCLC H460 xenografts. |
Alias | BDA-366 analog |
Molecular Weight | 435.52 |
Formula | C25H29N3O4 |
Cas No. | 1821496-27-8 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.